-
Loading metrics
Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects
-
Michael Callahan,
Roles Conceptualization, Investigation
Affiliation Division of Infectious Diseases, Massachusetts General Hospital, Massachusetts, United States of America
⨯ -
Anthony M. Treston,
Roles Formal analysis, Investigation, Writing – original draft, Writing – review & editing
Current address: Treadwell Therapeutics, Toronto, Canada
Affiliation Emergent BioSolutions Inc, Gaithersburg, Maryland, United States of America
⨯ - Grace Lin,
- Marla Smith,
- Brian Kaufman,
- Mansoora Khaliq,
- Lisa Evans DeWald,
- Kevin Spurgers,
- Kelly L. Warfield ,
- Preeya Lowe,
- Matthew Duchars,
-
Aruna Sampath,
Roles Conceptualization, Investigation
Current address: Dynavax Technologies Corporation, Emeryville, California, United States of America
Affiliation Emergent BioSolutions Inc, Gaithersburg, Maryland, United States of America
⨯ - Urban Ramstedt
https://orcid.org/0000-0002-6010-8422
Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects
- Michael Callahan,
- Anthony M. Treston,
- Grace Lin,
- Marla Smith,
- Brian Kaufman,
- Mansoora Khaliq,
- Lisa Evans DeWald,
- Kevin Spurgers,
- Kelly L. Warfield,
- Preeya Lowe
x
-
- Published: August 8, 2022
- https://doi.org/10.1371/journal.pntd.0010636